

MNOV, MGH, ARAY, HAYN, ZIOP, BAS Are Seasonally Ripe To Go Down In the Next Five Weeks
August 9, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of MediciNova Inc (NASDAQ:MNOV), MINCO GOLD CORP (AMEX:MGH), Accuray Inc (NASDAQ:ARAY), Haynes International Inc (NASDAQ:HAYN), ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Basic Energy Services Inc (NYSE:BAS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date MNOV MediciNova Inc -10.93% 100.00% (5 of 5) Monday, September 10th 2012 MGH MINCO GOLD CORP -6.21% 100.00% (6 of 6) Monday, August 13th 2012 ARAY Accuray Inc -12.62% 100.00% (5 of 5) Friday, September 21st 2012 HAYN Haynes International Inc -5.75% 66.67% (4 of 6) Monday, August 20th 2012 ZIOP ZIOPHARM Oncology Inc -9.82% 100.00% (6 of 6) Friday, September 7th 2012 BAS Basic Energy Services Inc -7.46% 66.67% (4 of 6) Wednesday, September 5th 2012MediciNova Inc (NASDAQ:MNOV) - MediciNova, Inc., a biopharmaceutical company, engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs principally in the United States. The companys development pipeline includes programs that are in clinical development for the treatment of asthma, acute exacerbations of asthma, multiple sclerosis, central nervous system disorders, interstitial cystitis, solid tumor cancers, generalized anxiety disorder/insomnia, preterm labor, and urinary incontinence. Its principal product development programs consist of MN-221, which completed Phase II clinical trial for the treatment of acute exacerbations of asthma, and completed Phase Ib clinical trial for the treatment of chronic obstructive pulmonary disease; MN-166 that has completed Phase II clinical trial for the treatment of multiple sclerosis; and AV411, which has advanced through multiple Phase I and IIa clinical trials for the treatment of central nervous system disorders. The companys other product development programs include MN-001, which completed Phase II/III clinical trial for the treatment of interstitial cystitis and an oral dosing formulation prototype for the treatment of bronchial asthma; MN-029 that completed Phase I clinical trial for the treatment of solid tumors; MN-305, which completed Phase II/III clinical trial for the treatment of generalized anxiety disorder and Phase II clinical trial for the treatment of insomnia; MN-221 that completed a Phase I clinical trial for the treatment of preterm labor; and MN-246, a Phase I clinical trial completed product for the treatment of urinary incontinence. Its preclinical development products comprise MN-447 and MN-462 for the treatment of thrombotic disorders. The company was founded in 2000 and is headquartered in San Diego, California.
MINCO GOLD CORP (AMEX:MGH) - Minco Gold Corporation, a mining company, through its subsidiaries, engages in the acquisition, exploration, evaluation, and development of mineral properties in the People's Republic of China and Canada. The company primarily explores for gold deposits, as well as for iron, silver, lead, zinc, and other base metals. It owns 16 gold properties covering approximately 1,000 square kilometers of mineral rights. The company was formerly known as Minco Mining & Metals Corporation and changed its name to Minco Gold Corporation in January 2007. Minco Gold Corporation was founded in 1982 and is headquartered in Vancouver, Canada.
Accuray Inc (NASDAQ:ARAY) - Accuray Incorporated designs, develops, and sells the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors. The CyberKnife system combines continuous image-guidance technology with a compact linear accelerator to deliver high doses of radiation to a tumor from different directions. It tracks, detects, and corrects for tumor and patient movement in real-time during the treatment. The CyberKnife systems components and technologies include compact X-band linear accelerator, which generates the radiation to destroy the tumor; robotic manipulator that allows doses of radiation to be delivered from any direction and position; real-time image-guidance system to continuously monitor and correct for patient and tumor movements; X-ray sources to generate X-ray images to determine the location of bony landmarks or implanted fiducials; and image detectors to capture high-resolution anatomical images. The company markets its product through a direct sales force in the United States and a combination of direct sales personnel and distributors internationally. Accuray Incorporated was incorporated in 1990 and is based in Sunnyvale, California.
Haynes International Inc (NASDAQ:HAYN) - Haynes International Inc. develops, manufactures, markets, and distributes high-performance nickel-and cobalt-based alloys in sheet, coil, and plate forms for use by the manufacturers of various equipments worldwide. The companys products consist of high-temperature resistant alloys (HTA) and corrosion resistant alloys (CRA). Its HTA products are used in the manufacture of jet engines for the aerospace market, gas turbine engines for power generation and waste incineration, and industrial heating equipments; and CRA products are used in various applications, including chemical processing, power plant emissions control, and hazardous waste treatment. The company also produces its products as seamless and welded tubulars, as well as in slab, bar, billet, and wire forms. In addition, it offers stainless steel and general purpose nickel alloys. Haynes International sells its products through its direct sales organization, as well as through a network of independent distributors and sales agents. The company was founded in 1912 and is headquartered in Kokomo, Indiana.
ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the development and commercialization of a portfolio of cancer drugs in North America. Its products under various stages of development and trials include Palifosfamide for the treatment of sarcoma, lymphoma, testicular, and other cancers; Darinaparsin, a mitochondrial-targeted agent for the treatment of various hematologic and solid cancers; and Indibulin, an oral tubulin binding agent that targets mitosis and cancer cell migration. The company has license agreements with DEKK-Tec, Inc.; and Baxter Healthcare Corporation, as well as a collaboration agreement Harmon Hill, LLC. ZIOPHARM Oncology, Inc. was founded in 2003 and is headquartered in New York, New York.
Basic Energy Services Inc (NYSE:BAS) - Basic Energy Services, Inc. provides a range of well site services to oil and gas drilling and producing companies in the United States. The companys Well Servicing segment provides services in a mobile well servicing rig, including installation and removal of downhole equipment, elimination of obstructions in the well bore, and plugging and abandonment services. This segment operates a fleet of 405 well servicing rigs and related equipment. Its Fluid Services segment provides oilfield fluid supply, transportation, and storage services, which include transportation of fluids used in drilling and workover operations; sale and transportation of fresh and brine water; operation of company-owned fresh water and brine source wells; rental of portable frac tanks and test tanks; and preparation, construction, and maintenance of access roads, drilling locations, and production facilities. This segment operates a fleet of 791 fluid services trucks and related assets, including specialized tank trucks, storage tanks, water wells, disposal facilities, and related equipment. The companys Completion and Remedial Services segment provides pressure pumping services, such as cementing, acidizing, fracturing, coiled tubing, and pressure testing; rental and fishing tools; cased-hole wireline services; and underbalanced drilling in low pressure and fluid sensitive reservoirs. It operates 142 pressure pumping units; 40 air compressor packages, including foam circulation units for underbalanced drilling; and 15 wireline units for cased-hole measurement and pipe recovery services. Basic Energy Services Contract Drilling segment engages in drilling of well bores. The company owns and operates nine land drilling rigs. It operates in onshore oil and natural gas producing regions located in Texas, New Mexico, Oklahoma, Kansas, Arkansas, Louisiana, Wyoming, North Dakota, Colorado, Utah, and Montana. The company is based in Midland, Texas.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641